Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs

Midlands - Coventry, Derby and Leicester
17 December 2014 19:06



South West - Exeter, Plymouth, Taunton, Torquay,
17 December 2014 17:49



Oxfordshire
17 December 2014 17:10


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
I want to thank Zenopa for their time and efforts in helping me during my job search, you have given me the extra confidence I need to keep me pro-active in my search.
Mohammed, 2011

DePuy Synthes appoints worldwide spinal division president

14 December 2012 12:28 in Medical Company Restructures


DePuy Synthes has announced the appointment of Max Reinhardt as the new worldwide president of its DePuy Synthes Spine business division.

Mr Reinhardt has been with the DePuy Spine company since 2002 and most recently served in the role of vice-president of worldwide marketing, a position he has occupied since early 2011.

Originally appointed as UK director of sales and marketing, he has moved through positions of escalating responsibility, playing a key role in integrating the global spine division of Synthes into DePuy following its acquisition by the Johnson and Johnson group earlier this year.

Following this merger, the combined company now has one of the largest and most diverse portfolios in the industry, including traditional and minimally invasive devices and solutions for a wide range of spinal disorders.

According to Johnson and Johnson's third-quarter financial report, the takeover of Synthes contributed significantly to the 6.5 percent year-over-year revenue growth experienced by the group during the three-month period.ADNFCR-8000103-ID-801506892-ADNFCR

Other news stories from 14/12/2012

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd